iShares China Large-Cap ETF vs Heron Therapeutics Inc — how do they compare? iShares China Large-Cap ETF trades at $35.38, while Heron Therapeutics Inc trades at $0.32 (market cap $61.47M). The key difference: iShares China Large-Cap ETF is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| FXI | HRTX | |
|---|---|---|
52-Week High | $41.75 | $1.49 |
52-Week Low | $31.59 | $0.32 |
Market Cap | — | $61.47M |
Sector | — | Health |
Enterprise Value | — | $168.21M |
Trailing returns across standard periods
Latest headlines on both assets
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index designed to measure the performance of the largest companies in the Chinese equity market that trade on the Stock Exchange of Hong Kong and are available to international investors. The fund is non-diversified.
Read more on FXI →Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →